Zobrazeno 1 - 10
of 52
pro vyhledávání: '"F, Van Wanzeele"'
Autor:
B. Van der Gucht, Sophie Degroote, An Mariman, Jolanda Pelgrom, Dirk Vogelaers, Dominique Vandijck, J. Vancauwenberghe, A. De Rick, Chris Verhofstede, F. Van Wanzeele, Peter Vermeir
Publikováno v:
Acta Clinica Belgica. 69:111-115
Since the era of highly active antiretroviral therapy (HAART), HIV is considered a chronic disease. Adherence to HAART is crucial for effectiveness. Non-adherence negatively impacts patient outcome and the larger economy. However, data on adherence a
Autor:
S De Wit, Patrick Lacor, Eric Florence, Bernard Vandercam, Jean Demonty, Nathan Clumeck, R Colebunders, F. Van Wanzeele, E. Van Wijngaerden
Publikováno v:
Acta clinica Belgica
Autor:
Chris Verhofstede, J Van Acker, Michel Langlois, Robert Hemmer, G van der Groen, Johan R. Boelaert, M. De Buyzere, Dirk De Bacquer, F. Van Wanzeele, Vic Arendt, Jean Plum, Joris R. Delanghe
Publikováno v:
AIDS. 12:1021-1026
Background: Three phenotypes of the antioxidant protein haptoglobin are known: Hp 1-1, Hp 2-1 and Hp 2-2. Objectives: To investigate the outcome of HIV infection according to haptoglobin type. Design and methods: Haptoglobin phenotypes were determine
Autor:
F. Van Wanzeele, Lidia Ruiz, François Schneider, P. Simons, K Van Vaerenbergh, Chris Verhofstede, Philippe Hermans, E. Van Wijngaerden, Jan Desmyter, B. Clotet, G. M Uyldermans, Anne-Mieke Vandamme, Lieven Stuyver, C. Evans, Jean-Claude Schmit, K. Van Laethem, E. De Clercq
Publikováno v:
ResearcherID
We evaluated the predictive value of baseline HIV-1 genotypic resistance mutations for failure of a nucleoside reverse transcriptase inhibitor (NRTI) containing therapy. The change in therapy of 88 HIV-1-infected patients was analyzed retrospectively
Autor:
E H, Gisolf, S, Jurriaans, J, Pelgrom, F, van Wanzeele, M E, van der Ende, K, Brinkman, M J, Borst, F, de Wolf, A J, Japour, S A, Danner
Publikováno v:
AIDS (London, England). 14(4)
To evaluate the effect of treatment with ritonavir (RTV)/saquinavir (SQV)/6 stavudine (D4T) or RTV/SQV alone, with treatment intensification if needed, in protease inhibitor- and D4T-naïve HIV-1-infected individuals.Multicentre, open-label, randomiz
Autor:
Sven A. Danner, Suzanne Jurriaans, M.E. van der Ende, Anthony J. Japour, J Pelgrom, F. De Wolf, M J Borst, Kees Brinkman, Elisabeth H. Gisolf, F. Van Wanzeele
Publikováno v:
Gisolf, E H, Jurriaans, S, Pelgrom, J, Van Wanzeele, F, Van der Ende, M E, Brinkman, K, Borst, M J, De Wolf, F, Japour, A J & Danner, S A 2000, ' The effect of treatment intensification in HIV-infection : A study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine ', AIDS, vol. 14, no. 4, pp. 405-413 . https://doi.org/10.1097/00002030-200003100-00014
AIDS, 14(4), 405-413. Lippincott Williams and Wilkins
AIDS, 14(4), 405-413. Lippincott Williams and Wilkins
Objective: To evaluate the effect of treatment with ritonavir (RTV)/saquinavir (SQV)/stavudine (D4T) or RTV/SQV alone, with treatment intensification if needed, in protease inhibitor- and D4T-naive HIV-1-infected individuals. Design: Multicentre, ope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5064bde06fedcd5bb9e87d2f9d0f0d4
https://research.vumc.nl/en/publications/712f092c-9650-44b5-b919-68e5b69a77c5
https://research.vumc.nl/en/publications/712f092c-9650-44b5-b919-68e5b69a77c5
Autor:
S, Staszewski, V, Miller, A, Kober, R, Colebunders, B, Vandercam, J, Delescluse, N, Clumeck, F, Van Wanzeele, M, De Brabander, J, De Creé, M, Moeremans, K, Andries, C, Boucher, P, Stoffels, P A, Janssen
Publikováno v:
Antiviral therapy. 1(1)
Publikováno v:
AIDS (London, England). 7(11)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.